Inflammatory Bowel Disease Market Size, Share, Trends, Growth, and Forecasts for 2025 - 2032

Inflammatory Bowel Disease Market Size by Disease Type (Crohn's Disease, Ulcerative Colitis), Drug Class (Aminosalicylates, Corticosteroids, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), and Regional Analysis for 2025 - 2032

ID: PMRREP34735

Format: PPT*, PDF, EXCEL

Last Updated: 23 Jul 2025

Industry: Chemicals and Materials

Number of Pages: 191

Persistence Market Research Report, Market Growth and Regional Outlook

Table of Content

  1. Executive Summary
    1. Global Inflammatory Bowel Disease Market Snapshot, 2025 and 2032
    2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
    3. Macro-economic Factors
      1. Global Sectoral Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors - Relevance and Impact
  3. Value Added Insights
    1. Tool Adoption Analysis
    2. Regulatory Landscape
    3. Value Chain Analysis
    4. PESTLE Analysis
    5. Porter’s Five Force Analysis
  4. Price Analysis, 2024A
    1. Key Highlights
    2. Key Factors Impacting Deployment Costs
    3. Pricing Analysis, By Drug Class
  5. Global Inflammatory Bowel Disease Market Outlook
    1. Key Highlights
      1. Market Volume (Units) Projections
      2. Market Size (US$ Bn) and Y-o-Y Growth
      3. Absolute $ Opportunity
    2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2019-2024
      2. Current Market Size (US$ Bn) Analysis and Forecast, 2025 - 2032
    3. Global Inflammatory Bowel Disease Market Outlook: Disease Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Disease Type, 2019 - 2024
      3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Disease Type, 2025 - 2032
        1. Crohn’s Disease
        2. Ulcerative Colitis
      4. Market Attractiveness Analysis: Disease Type
    4. Global Inflammatory Bowel Disease Market Outlook: Drug Class
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Drug Class, 2019 - 2024
      3. Current Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2025 - 2032
        1. Aminosalicylates
        2. Corticosteroids
        3. Immunomodulators
        4. Others
      4. Market Attractiveness Analysis: Drug Class
    5. Global Inflammatory Bowel Disease Market Outlook: Distribution Channel
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019 - 2024
      3. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. E-Commerce Platforms
        4. Others
      4. Market Attractiveness Analysis: Distribution Channel
  6. Global Inflammatory Bowel Disease Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019 - 2024
    3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2025 - 2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  7. North America Inflammatory Bowel Disease Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Disease Type
      3. By Drug Class
      4. By Distribution Channel
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. U.S.
      2. Canada
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Disease Type, 2025 - 2032
      1. Crohn’s Disease
      2. Ulcerative Colitis
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2025 - 2032
      1. Aminosalicylates
      2. Corticosteroids
      3. Immunomodulators
      4. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. E-Commerce Platforms
      4. Others
    7. Market Attractiveness Analysis
  8. Europe Inflammatory Bowel Disease Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Disease Type
      3. By Drug Class
      4. By Distribution Channel
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Disease Type, 2025 - 2032
      1. Crohn’s Disease
      2. Ulcerative Colitis
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2025 - 2032
      1. Aminosalicylates
      2. Corticosteroids
      3. Immunomodulators
      4. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. E-Commerce Platforms
      4. Others
    7. Market Attractiveness Analysis
  9. East Asia Inflammatory Bowel Disease Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Disease Type
      3. By Drug Class
      4. By Distribution Channel
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. China
      2. Japan
      3. South Korea
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Disease Type, 2025 - 2032
      1. Crohn’s Disease
      2. Ulcerative Colitis
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2025 - 2032
      1. Aminosalicylates
      2. Corticosteroids
      3. Immunomodulators
      4. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. E-Commerce Platforms
      4. Others
    7. Market Attractiveness Analysis
  10. South Asia & Oceania Inflammatory Bowel Disease Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Disease Type
      3. By Drug Class
      4. By Distribution Channel
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Disease Type, 2025 - 2032
      1. Crohn’s Disease
      2. Ulcerative Colitis
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2025 - 2032
      1. Aminosalicylates
      2. Corticosteroids
      3. Immunomodulators
      4. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. E-Commerce Platforms
      4. Others
    7. Market Attractiveness Analysis
  11. Latin America Inflammatory Bowel Disease Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Disease Type
      3. By Drug Class
      4. By Distribution Channel
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Disease Type, 2025 - 2032
      1. Crohn’s Disease
      2. Ulcerative Colitis
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2025 - 2032
      1. Aminosalicylates
      2. Corticosteroids
      3. Immunomodulators
      4. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. E-Commerce Platforms
      4. Others
    7. Market Attractiveness Analysis
  12. Middle East & Africa Inflammatory Bowel Disease Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Disease Type
      3. By Drug Class
      4. By Distribution Channel
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Disease Type, 2025 - 2032
      1. Crohn’s Disease
      2. Ulcerative Colitis
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2025 - 2032
      1. Aminosalicylates
      2. Corticosteroids
      3. Immunomodulators
      4. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. E-Commerce Platforms
      4. Others
    7. Market Attractiveness Analysis
  13. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
      1. AbbVie Inc.
        1. Overview
        2. Segments and Deployments
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Janssen Biotech, Inc.
      3. Pfizer Inc.
      4. Takeda Pharmaceutical Company Limited
      5. Ferring Pharmaceuticals
      6. Amgen Inc.
      7. Eli Lilly and Company
      8. Novartis AG
      9. Bristol-Myers Squibb
      10. Johnson & Johnson
      11. Merck & Co., Inc.
      12. GlaxoSmithKline plc
  14. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations

Thank you for taking time to visit our website, click like if you found the information on this page useful?

This site uses cookies, including third-party cookies, that help us to provide and improve our services.
Google translate